This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. slid 4.1% to $634.14 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.2% to 5,776.65 and the Dow Jones Industrial Average rising 0.0% to 42,587.50.
Regeneron Pharmaceuticals Inc. closed 47.6% below its 52-week high of $1,211.20, which the company reached on August 27th.
The stock underperformed when compared to some of its competitors, as Amgen Inc. fell 2.4% to $306.86, Moderna Inc. fell 0.9% to $33.85, and Gilead Sciences Inc. rose 1.08% to $107.89.
Trading volume totaled 848,623, compared to the 50-day average of 967,305.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 25, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.